Table 3.
The number of patients receiving each treatment per model year in base case scenarios with and without RefluxStop
| Modeled year | Scenario without RefluxStop | Scenario with RefluxStop | |||||
|---|---|---|---|---|---|---|---|
| PPI-based medical management | Nissen fundoplication | MSA | PPI-based medical management | Nissen fundoplication | MSA | RefluxStop | |
| 1 | 925,749 | 739 | 84 | 925,749 | 697 | 84 | 42 |
| 2 | 18,645 | 735 | 85 | 18,645 | 651 | 85 | 84 |
| 3 | 18,682 | 732 | 86 | 18,682 | 608 | 86 | 124 |
| 4 | 18,685 | 730 | 86 | 16,685 | 579 | 86 | 151 |
| 5 | 18,689 | 727 | 87 | 18,689 | 550 | 87 | 177 |
| Total | 1,000,450 | 3663 | 428 | 1,000,450 | 3085 | 428 | 578 |
MSA magnetic sphincter augmentation, PPI proton pump inhibitor